Related Articles
Antitumor activity of ZD6474 in a metastatic orthotopic brain tumor model
EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration
Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma
The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer
Application of molecular targeted therapies in the treatment of head and neck squamous cell carcinoma (Review)